GCAT Advisory Boards

GCAT Scientific Advisory Board

The Scientific Advisory Council has the function of advising, and its mission is to ensure the scientific quality of the GCAT project and its strategic development. Its function is to advise on the direction and fulfillment of the objectives of the project, and to advise on the strategic research activities to be developed by the project

The Scientific Advisory Board has an internal operating regulations, which establish the dynamics of operation to guarantee independence, the absence of conflict of interest and the form of relationship with the GCAT Steering Committee.

The members will be appointed by the Steering Committee for renewable periods of five years.

Ethics Committee Associated with GCAT

The Ethical Committee for Clinical Research (CEIC) of the Germans Trias Univesity Hospital oversees the ethical and legal considerations for the GCAT.

The CEIC is a key element in the development of the GCAT Project as its mission is to ensure that biomedical research is carried out correctly from a methodological, ethical and legal point of view and that the rights, benefits and auntomia of the subjects is respected.

GCAT Scientific Evaluation Board

The Scientific Evaluation Board  is an independent body that oversees the scientific and technical quality of all the research projects carried out by third parties. The Evaluation Committee provides general scientific advice on technical procedures established in the operation of the biobank (scientific adequacy, technical suitability, good practices, quality, safety and traceability) and evaluates the requests for access to samples and data.

The External Board is composed of at least four members with expertise in the field of biomedical research and led by a member of the GCAT Steering Committee.

To guarantee an independent view with no conflict of interest, this board is run according to strict rules. Members are designated by the GCAT Steering Committee for renewable periods of 2 years.

Current members

Dr. Víctor Moreno(ELIMINAR) is currently Director of the del Unit of Biomarkers and Susceptibility, Cancer Prevention and Control Program at Catalan Institute of Oncology (ICO) and GCAT researcher.


ORCID 0000-0002-2818-5487

Dr. Miquel Àngel Peinado(ELIMINAR) is an associate director of the IGTP and leader of the Epigenetic Mechanisms of Cancer and Cell Differentiation group that is part of the Program of Predictive and Personalized Medicine of the Cancer (PMPPC)


ORCID 0000-0002-4090-793X

Dr. Ignacio Blanco(ELIMINAR) is vice-president of the Spanish Association of Human Genetics as well as coordinator of the Clinical Genetics and Counseling Program at the Germans Trias i Pujol University Hospital in Badalona


ORCID 0000-0002-7414-7481

Dr. Eduard Serra(ELIMINAR) leads the IGTP Hereditary Cancer group and coordinates the Joint Program for Molecular Diagnostics of ICO-PMPPC at the IGTP


ORCID 0000-0003-2895-9857

Dr. Lauro Sumoy(ELIMINAR) is the director of the Genomics Unit of the Predictive and Personalized Cancer Medicine Program (PMPPC) and senior researcher of the Genomics and Bioinformatics group at the IGTP


ORCID 0000-0003-0005-4618

Former members:

Dr. Manuel Perucho(ELIMINAR) is currently Director of the Program for Predictive and Personalized Cancer Medicine (PMPPC) at the IGTP


ORCID 0000-0002-2169-2662